Provided by Tiger Trade Technology Pte. Ltd.

InflaRx N.V.

2.12
+0.02501.20%
Volume:430.95K
Turnover:924.28K
Market Cap:311.52M
PE:-3.70
High:2.20
Open:2.15
Low:2.10
Close:2.09
52wk High:2.95
52wk Low:0.7984
Shares:147.29M
Float Shares:98.11M
Volume Ratio:0.95
T/O Rate:0.44%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5715
EPS(LYR):-0.7963
ROE:-38.52%
ROA:-18.54%
PB:1.84
PE(LYR):-2.66

Loading ...

InflaRx Initiated at Buy by Needham

Dow Jones
·
Yesterday

Needham Initiates InflaRx at Buy With $8 Price Target

MT Newswires Live
·
Yesterday

InflaRx Nv : Needham Initiates Coverage with Buy Rating; Target Price $8

THOMSON REUTERS
·
Yesterday

InflaRx to Present at H.C. Wainwright Annual Global Investment Conference

Reuters
·
Aug 20

InflaRx Price Target Raised to $6.00/Share from $4.00 by Cantor Fitzgerald

Dow Jones
·
Aug 07

Analysts’ Top Healthcare Picks: InflaRx (IFRX), CG Oncology, Inc. (CGON)

TIPRANKS
·
Aug 07

InflaRx NV Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 06

InflaRx Posts H1 Loss as Warrant Fair-Value Hit Outweighs FX Gains, R&D Spending Falls

Reuters
·
Aug 06

InflaRx H1 FY26 Net Loss Narrows to €16.2 Million

Reuters
·
Aug 06

InflaRx Q2 EPS $(0.10) Misses $(0.08) Estimate

Benzinga Earnings
·
Aug 06

Press Release: InflaRx Reports Second Quarter 2026 Results and Highlights Key Achievements and Expected Milestones

Dow Jones
·
Aug 06

InflaRx NV Expected to Post a Loss of 6 Cents a Share - Earnings Preview

Reuters
·
Aug 04

InflaRx to Report Second-quarter Results Before Market Open

Reuters
·
Jul 30

Analysts Offer Insights on Healthcare Companies: InflaRx (IFRX) and Baxter International (BAX)

TIPRANKS
·
Jul 27

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Jul 21

InflaRx (IFRX) Gets a Buy from Oppenheimer

TIPRANKS
·
Jun 30

Inflarx Weighs Broader Europe AAV Strategy, Plans EMA Talks on Vilobelimab and Izicopan

Reuters
·
Jun 30

Palisade Bio adds Robert Baltera, Jordan Zwick to board of directors

Reuters
·
Jun 11

InflaRx price target raised to $8 from $6 at H.C. Wainwright

TIPRANKS
·
May 12

InflaRx Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
May 12